Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
$1.52+0.09 (+6.29%)
Close on Nov 17, 2026Market cap $72.03MP/E –Yield –
Zhengye Biotechnology gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 20.5%, against 49.0% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.5% | −28.5 |
| FY2024 | Dec 31, 2024 | 49.0% | −6.5 |
| FY2023 | Dec 31, 2023 | 55.5% | −1.3 |
| FY2022 | Dec 31, 2022 | 56.8% | – |
See a number that looks wrong?